PhRMA and Novartis each challenged West Virginia's new 340B contract pharmacy access law in a federal district court.

Two Drug Industry Lawsuits Challenge West Virginia’s 340B Contract Pharmacy Access Law

An influential drug industry group and a major drugmaker each filed lawsuits challenging West Virginia’s 340B contract pharmacy access law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at